【TaiGen】The Company's Board of Directors Resolves to Waive Non-Compete Restrictions for Managers
TaiGen announced that its Board of Directors approved waiving non-compete restrictions for Chairman Huan-Ching Hsu and General Manager Ya-Chun Wang, allowing them to concurrently hold positions in its wholly-owned US subsidiary, TCM Life Science Inc. This clarifies the global roles of the management team.
📋 Article Processing Timeline
- 📰 Published: May 7, 2026 at 09:00
- 🔍 Collected: May 8, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 8, 2026 at 08:05 (5 min after Collected)
1.Date of Board of Directors resolution:2026/05/07
2.Name and title of managers permitted to engage in competitive activities:
Chairman Huan-Ching Hsu
General Manager Ya-Chun Wang
3.Items of competitive activities permitted:
TCM Life Science Inc. is a 100% owned US subsidiary of the Company.
Huan-Ching Hsu / Chairman of TCM Life Science Inc.
Ya-Chun Wang / Director and CEO of TCM Life Science Inc.
4.Period during which competitive activities are permitted:During their tenure as managers of the Company.
5.Resolution status (please explain the voting result according to Article 32 of the Company Act):
Chairman Huan-Ching Hsu and Director Ya-Chun Wang recused themselves. The remaining attending directors unanimously approved the proposal.
6.If the permitted competitive activity involves business operations in mainland China, name and title of managers (if not applicable to mainland China operations, please enter "Not applicable" below):Not applicable
7.Name of the company and position held in the mainland China business:Not applicable
8.Address of the mainland China business:Not applicable
9.Business items of the mainland China business:Not applicable
10.Extent of impact on the Company's financial and business operations:None
11.If managers invest in the mainland China business, their investment amount and shareholding ratio:Not applicable
12.Other matters that need to be specified:None
2.Name and title of managers permitted to engage in competitive activities:
Chairman Huan-Ching Hsu
General Manager Ya-Chun Wang
3.Items of competitive activities permitted:
TCM Life Science Inc. is a 100% owned US subsidiary of the Company.
Huan-Ching Hsu / Chairman of TCM Life Science Inc.
Ya-Chun Wang / Director and CEO of TCM Life Science Inc.
4.Period during which competitive activities are permitted:During their tenure as managers of the Company.
5.Resolution status (please explain the voting result according to Article 32 of the Company Act):
Chairman Huan-Ching Hsu and Director Ya-Chun Wang recused themselves. The remaining attending directors unanimously approved the proposal.
6.If the permitted competitive activity involves business operations in mainland China, name and title of managers (if not applicable to mainland China operations, please enter "Not applicable" below):Not applicable
7.Name of the company and position held in the mainland China business:Not applicable
8.Address of the mainland China business:Not applicable
9.Business items of the mainland China business:Not applicable
10.Extent of impact on the Company's financial and business operations:None
11.If managers invest in the mainland China business, their investment amount and shareholding ratio:Not applicable
12.Other matters that need to be specified:None